Wells Fargo & Company »

Cerevel Therapeutics Hldng I shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $949k 22k 42.28
2023-12-31 $854k 20k 42.40
2023-09-30 $1.1M 50k 21.83
2023-06-30 $2.0M 64k 31.79
2022-12-31 $502k 16k 31.54
2022-09-30 $57k 2.0k 28.38
2022-06-30 $61k 2.3k 26.60
2022-03-31 $339k 9.7k 35.02
2021-12-31 $761k 24k 32.41
2021-09-30 $1.4M 47k 29.50
2021-03-31 $0 1 0.00
2020-12-31 $4.0k 240 16.67